InnovaccerPRIVATE · FOUNDED 2014Each bar is the last disclosed mark — $1B for Alloy Therapeutics (post-money, Apr 2026) and $3.45B for Innovaccer (post-money, Jan 2025).

InnovaccerPRIVATEHealth · US · 2014
The $3.45B tells you…Both marks are post-money, so 3.45× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.
Alloy Therapeutics' sector is Biotech; Innovaccer's sector is healthcare technology / agentic AI for health data.
Alloy Therapeutics is valued at $1B, and Innovaccer at $3.5B.
Alloy Therapeutics' headquarters is in United States; Innovaccer's is in San Francisco, California.
Alloy Therapeutics' status is private; Innovaccer's status is private.
Alloy Therapeutics is headquartered in United States, and Innovaccer in United States.